233 related articles for article (PubMed ID: 3033290)
1. Effect of internal viral sequences on the utility of retroviral vectors.
Armentano D; Yu SF; Kantoff PW; von Ruden T; Anderson WF; Gilboa E
J Virol; 1987 May; 61(5):1647-50. PubMed ID: 3033290
[TBL] [Abstract][Full Text] [Related]
2. Development of improved adenosine deaminase retroviral vectors.
Onodera M; Nelson DM; Yachie A; Jagadeesh GJ; Bunnell BA; Morgan RA; Blaese RM
J Virol; 1998 Mar; 72(3):1769-74. PubMed ID: 9499026
[TBL] [Abstract][Full Text] [Related]
3. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy.
Morgan RA; Couture L; Elroy-Stein O; Ragheb J; Moss B; Anderson WF
Nucleic Acids Res; 1992 Mar; 20(6):1293-9. PubMed ID: 1313966
[TBL] [Abstract][Full Text] [Related]
4. Retroviral vectors produced in the cytoplasmic vaccinia virus system transduce intron-containing genes.
Konetschny C; Holzer GW; Falkner FG
J Virol; 2002 Feb; 76(3):1236-43. PubMed ID: 11773399
[TBL] [Abstract][Full Text] [Related]
5. Expression of human adenosine deaminase in murine haematopoietic progenitor cells following retroviral transfer.
Belmont JW; Henkel-Tigges J; Chang SM; Wager-Smith K; Kellems RE; Dick JE; Magli MC; Phillips RA; Bernstein A; Caskey CT
Nature; 1986 Jul 24-30; 322(6077):385-7. PubMed ID: 3016551
[TBL] [Abstract][Full Text] [Related]
6. Presence of a retroviral encapsidation sequence in nonretroviral RNA increases the efficiency of formation of cDNA genes.
Dornburg R; Temin HM
J Virol; 1990 Feb; 64(2):886-9. PubMed ID: 2153250
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of lymphoid-specific enhancer addition or substitution in a basic retrovirus vector.
Moore KA; Scarpa M; Kooyer S; Utter A; Caskey CT; Belmont JW
Hum Gene Ther; 1991; 2(4):307-15. PubMed ID: 1838933
[TBL] [Abstract][Full Text] [Related]
8. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
Couture LA; Mullen CA; Morgan RA
Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129
[TBL] [Abstract][Full Text] [Related]
9. Long-term expression of human adenosine deaminase in mice after transplantation of bone marrow infected with amphotropic retroviral vectors.
Osborne WR; Hock RA; Kaleko M; Miller AD
Hum Gene Ther; 1990; 1(1):31-41. PubMed ID: 2081183
[TBL] [Abstract][Full Text] [Related]
10. An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency.
Ferrari G; Rossini S; Giavazzi R; Maggioni D; Nobili N; Soldati M; Ungers G; Mavilio F; Gilboa E; Bordignon C
Science; 1991 Mar; 251(4999):1363-6. PubMed ID: 1848369
[TBL] [Abstract][Full Text] [Related]
11. Correction of ADA deficiency in human T lymphocytes using retroviral-mediated gene transfer.
Culver KW; Osborne WR; Miller AD; Fleisher TA; Berger M; Anderson WF; Blaese RM
Transplant Proc; 1991 Feb; 23(1 Pt 1):170-1. PubMed ID: 1846711
[No Abstract] [Full Text] [Related]
12. Retroviral vector gene expression in F9 embryonal carcinoma cells.
Linney E; Neill SD; Prestridge DS
J Virol; 1987 Oct; 61(10):3248-53. PubMed ID: 3041045
[TBL] [Abstract][Full Text] [Related]
13. Introduction of sequences encoding functional human adenosine deaminase into mouse cells using a retroviral shuttle system.
Valerio D; Duyvesteyn MG; van der Eb AJ
Gene; 1985; 34(2-3):163-8. PubMed ID: 4007492
[TBL] [Abstract][Full Text] [Related]
14. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region.
Bender MA; Palmer TD; Gelinas RE; Miller AD
J Virol; 1987 May; 61(5):1639-46. PubMed ID: 3502707
[TBL] [Abstract][Full Text] [Related]
15. Efficient gene transfer into primary murine lymphocytes obviating the need for drug selection.
Kuo ML; Sutkowski N; Ron Y; Dougherty JP
Blood; 1993 Aug; 82(3):845-52. PubMed ID: 8393352
[TBL] [Abstract][Full Text] [Related]
16. Packaging of intron-containing genes into retrovirus vectors by alphavirus vectors.
Li KJ; Garoff H
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3650-4. PubMed ID: 9520420
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an internal ribosomal entry segment within the 5' leader of avian reticuloendotheliosis virus type A RNA and development of novel MLV-REV-based retroviral vectors.
López-Lastra M; Gabus C; Darlix JL
Hum Gene Ther; 1997 Nov; 8(16):1855-65. PubMed ID: 9382952
[TBL] [Abstract][Full Text] [Related]
18. Expression of phosphoenolpyruvate carboxykinase (PEPCK) chimeras in renal epithelial cells. Retention of appropriate physiological responsiveness using enhancerless retroviral vectors.
Pollock AS; Lovett DH
Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):725-32. PubMed ID: 1377912
[TBL] [Abstract][Full Text] [Related]
19. Identification of cellular promoters by using a retrovirus promoter trap.
von Melchner H; Ruley HE
J Virol; 1989 Aug; 63(8):3227-33. PubMed ID: 2545900
[TBL] [Abstract][Full Text] [Related]
20. L-histidinol provides effective selection of retrovirus-vector-transduced keratinocytes without impairing their proliferative potential.
Stockschlaeder MA; Storb R; Osborne WR; Miller AD
Hum Gene Ther; 1991; 2(1):33-9. PubMed ID: 1650586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
